The Enterprise Value as of November 2024 (TTM) for Propanc Biopharma, Inc. (PPCB) is 1.13M

According to Propanc Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.13M. This represents a change of 4.01% compared to the average of 1.09M of the last 4 quarters.

Propanc Biopharma, Inc. (PPCB) Historical Enterprise Value (quarterly & annually)

How has PPCB Enterprise Value performed in the past?

The mean historical Enterprise Value of Propanc Biopharma, Inc. over the last ten years is 6.12M. The current 1.13M Enterprise Value has changed 1.75% with respect to the historical average. Over the past ten years (40 quarters), PPCB's Enterprise Value was at its highest in in the June 2015 quarter at 24.19M. The Enterprise Value was at its lowest in in the December 2014 quarter at 676.39K.

Propanc Biopharma, Inc. (PPCB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Propanc Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Propanc Biopharma, Inc. (PPCB) Average Enterprise Value

How has PPCB Enterprise Value performed in the past?

The current Enterprise Value of Propanc Biopharma, Inc. (PPCB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Propanc Biopharma, Inc. (PPCB) Enterprise Value vs. Peers

How is PPCB’s Enterprise Value compared to its peers?

Propanc Biopharma, Inc.’s Enterprise Value is less than Ocean Biomedical, Inc. (42.20M), greater than Enveric Biosciences, Inc. (636.29K), less than Hepion Pharmaceuticals, Inc. (1.72M), less than Elevation Oncology, Inc. (2.36M), greater than AVROBIO, Inc. (-85302404.00), greater than CohBar, Inc. (-4506335.00), less than Zura Bio Limited (90.25M), less than CureVac N.V. (395.14M), less than Reata Pharmaceuticals, Inc. (6.68B), less than Krystal Biotech, Inc. (4.54B), less than Vir Biotechnology, Inc. (1.02B),

Build a custom stock screener for Propanc Biopharma, Inc. (PPCB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Propanc Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Propanc Biopharma, Inc. (PPCB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Propanc Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.